Download Citation
Article Source:
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
Atkinson JM,
Rank KB,
Zeng Y,
Capen A,
Yadav V,
et al.
(2015)
Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.
PLOS ONE 10(4): e0125028.
https://doi.org/10.1371/journal.pone.0125028